Title: Prohibits the Sale of Inhalable Cannabis Products Containing THC Derived from Industrial Hemp
Signed by Governor Gavin Newsom
Title: Prohibits the Sale of Inhalable Cannabis Products Containing THC Derived from Industrial Hemp
Vote to concur with Senate amendments and pass a bill that prohibits the sale of inhalable cannabis products containing THC derived from industrial hemp in California.
Prohibits retailers that sell cigarettes or tobacco products from possessing, storing, or owning cannabis (Sec. 1).
Requires a licensed manufacturer to only use cannabinoid concentrates and extracts that are manufactured exclusively from licensed cannabis cultivators (Sec. 2).
Prohibits licensees from possessing, transporting, distributing, manufacturing, or selling industrial hemp from a licensed premises (Sec. 2).
Defines Cannabinoid as a chemical compound that includes THC and CBD (Sec. 3).
Specifies that individuals engaging in commercial cannabis activity without a license are subject to fines up to three times the amount of the license fee for every violation (Sec. 8).
Authorizes peace officers to seize cannabis, industrial hemp, and cannabis products if the product is subject to recall or embargo, related to an investigation, and violates other codes and programs (Sec. 9).
Specifies that cannabis products are adulterated if they have been packaged in a contaminated environment, have decomposed parts, contain poisonous substances, and the cultivation environment is not up to standards (Sec. 10).
Establishes a track and trace program for reporting the movement of cannabis, industrial hemp, and cannabis products (Sec. 13).
Specifies that the California Department of Tax and Fee Administration will track the cultivation tax in the program (Sec. 14).
Requires the department to implement a unique identification program for cannabis and cannabis products (Sec. 15).
Specifies that the program will include the identification of permitted quantities of cannabis plants at a cultivation site and identification of harvest batches and manufactured products (Sec. 15).
Requires retailers to have a licensed premise of a physical location from where commercial cannabis activities are conducted (Sec. 16).
Prohibits the sale, offer, or provision of alcoholic beverages that contain cannabinoids (Sec. 17).
Prohibits false advertisement of commercial cannabis products (Sec. 21).
Specifies that any individual who sells, dispenses, distributes, advertises through labeling or marking synthetic cannabinoids is guilty of a misdemeanor that is punishable by up to 6 months in jail or a fine of no more than $1,000 (Sec. 27).
Prohibits industrial hemp products in medical devices, prescription drugs, products containing tobacco or nicotine, and alcoholic beverages (Sec. 34).
Prohibits the sale of raw hemp products without a certificate of analysis from an independent laboratory (Sec. 41).
Title: Prohibits the Sale of Inhalable Cannabis Products Containing THC Derived from Industrial Hemp
Vote to amend and pass a bill that prohibits the sale of inhalable cannabis products containing THC derived from industrial hemp in California.
Prohibits retailers that sell cigarettes or tobacco products from possessing, storing, or owning cannabis (Sec. 1).
Requires a licensed manufacturer to only use cannabinoid concentrates and extracts that are manufactured exclusively from licensed cannabis cultivators (Sec. 2).
Prohibits licensees from possessing, transporting, distributing, manufacturing, or selling industrial hemp from a licensed premises (Sec. 2).
Defines Cannabinoid as a chemical compound that includes THC and CBD (Sec. 3).
Specifies that individuals engaging in commercial cannabis activity without a license are subject to fines up to three times the amount of the license fee for every violation (Sec. 8).
Authorizes peace officers to seize cannabis, industrial hemp, and cannabis products if the product is subject to recall or embargo, related to an investigation, and violates other codes and programs (Sec. 9).
Specifies that cannabis products are adulterated if they have been packaged in a contaminated environment, have decomposed parts, contain poisonous substances, and the cultivation environment is not up to standards (Sec. 10).
Establishes a track and trace program for reporting the movement of cannabis, industrial hemp, and cannabis products (Sec. 13).
Specifies that the California Department of Tax and Fee Administration will track the cultivation tax in the program (Sec. 14).
Requires the department to implement a unique identification program for cannabis and cannabis products (Sec. 15).
Specifies that the program will include the identification of permitted quantities of cannabis plants at a cultivation site and identification of harvest batches and manufactured products (Sec. 15).
Requires retailers to have a licensed premise of a physical location from where commercial cannabis activities are conducted (Sec. 16).
Prohibits the sale, offer, or provision of alcoholic beverages that contain cannabinoids (Sec. 17).
Prohibits false advertisement of commercial cannabis products (Sec. 21).
Specifies that any individual who sells, dispenses, distributes, advertises through labeling or marking synthetic cannabinoids is guilty of a misdemeanor that is punishable by up to 6 months in jail or a fine of no more than $1,000 (Sec. 27).
Prohibits industrial hemp products in medical devices, prescription drugs, products containing tobacco or nicotine, and alcoholic beverages (Sec. 34).
Prohibits the sale of raw hemp products without a certificate of analysis from an independent laboratory (Sec. 41).
Title: Prohibits the Sale of Inhalable Cannabis Products Containing THC Derived from Industrial Hemp
Vote to pass a bill that prohibits the sale of inhalable cannabis products containing THC derived from industrial hemp in California.
Prohibits retailers that sell cigarettes or tobacco products from possessing, storing, or owning cannabis (Sec. 1).
Requires a licensed manufacturer to only use cannabinoid concentrates and extracts that are manufactured exclusively from licensed cannabis cultivators (Sec. 2).
Prohibits licensees from possessing, transporting, distributing, manufacturing, or selling industrial hemp from a licensed premises (Sec. 2).
Defines Cannabinoid as a chemical compound that includes THC and CBD (Sec. 3).
Specifies that individuals engaging in commercial cannabis activity without a license are subject to fines up to three times the amount of the license fee for every violation (Sec. 8).
Authorizes peace officers to seize cannabis, industrial hemp, and cannabis products if the product is subject to recall or embargo, related to an investigation, and violates other codes and programs (Sec. 9).
Specifies that cannabis products are adulterated if they have been packaged in a contaminated environment, have decomposed parts, contain poisonous substances, and the cultivation environment is not up to standards (Sec. 10).
Establishes a track and trace program for reporting the movement of cannabis, industrial hemp, and cannabis products (Sec. 13).
Specifies that the California Department of Tax and Fee Administration will track the cultivation tax in the program (Sec. 14).
Requires the department to implement a unique identification program for cannabis and cannabis products (Sec. 15).
Specifies that the program will include the identification of permitted quantities of cannabis plants at a cultivation site and identification of harvest batches and manufactured products (Sec. 15).
Requires retailers to have a licensed premise of a physical location from where commercial cannabis activities are conducted (Sec. 16).
Prohibits the sale, offer, or provision of alcoholic beverages that contain cannabinoids (Sec. 17).
Prohibits false advertisement of commercial cannabis products (Sec. 21).
Specifies that any individual who sells, dispenses, distributes, advertises through labeling or marking synthetic cannabinoids is guilty of a misdemeanor that is punishable by up to 6 months in jail or a fine of no more than $1,000 (Sec. 27).
Prohibits industrial hemp products in medical devices, prescription drugs, products containing tobacco or nicotine, and alcoholic beverages (Sec. 34).
Prohibits the sale of raw hemp products without a certificate of analysis from an independent laboratory (Sec. 41).
Title: Prohibits the Sale of Inhalable Cannabis Products Containing THC Derived from Industrial Hemp